Planning and Evaluation of Bioequivalence Studies of Telmisartan Generic Drug Products
Introduction. Telmisartan is a modern antihypertensive drug, from the group of angiotensin II receptor antagonists, which, recently, has been the purpose of the development and registration of generic drug. The pharmaceutical development of telmisartan generics and their evaluation in bioequivalence...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2019-09-01
|
| Col·lecció: | Разработка и регистрация лекарственных средств |
| Matèries: | |
| Accés en línia: | https://www.pharmjournal.ru/jour/article/view/720 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|